C. Yamalı And S. Donmez, "Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease," MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1, pp.1, 2023
Yamalı, C. And Donmez, S. 2023. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease. MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1 , 1.
Yamalı, C., & Donmez, S., (2023). Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease. MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1, 1.
Yamalı, CEM, And Seyda Donmez. "Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease," MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1, 1, 2023
Yamalı, CEM And Donmez, Seyda. "Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease." MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1, pp.1, 2023
Yamalı, C. And Donmez, S. (2023) . "Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease." MINI-REVIEWS IN MEDICINAL CHEMISTRY , vol.1, no.1, p.1.
@article{article, author={CEM YAMALI And author={Seyda Donmez}, title={Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer’s Disease}, journal={MINI-REVIEWS IN MEDICINAL CHEMISTRY}, year=2023, pages={1} }